Sp1 contributes to radioresistance of cervical cancer through targeting G2/M cell cycle checkpoint CDK1

References

• Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–E386. doi:10.1002/ijc.2921025220842
   PubMed Web of Science ®Google Scholar
• Ning S, Nemeth JA, Hanson RL, Forsythe K, Knox SJ. Anti-integrin monoclonal antibody CNTO 95 enhances the therapeutic efficacy of fractionated radiation therapy in vivo. Mol Cancer Ther. 2008;7(6):1569–1578. doi:10.1158/1535-7163.MCT-08-028818566227
   PubMed Web of Science ®Google Scholar
• Vizcaino C, Mansilla S, Portugal J. Sp1 transcription factor: a long-standing target in cancer chemotherapy. Pharmacol Ther. 2015;152:111–124. doi:10.1016/j.pharmthera.2015.05.00825960131
   PubMed Web of Science ®Google Scholar
• Li L, Davie JR. The role of Sp1 and Sp3 in normal and cancer cell biology. Ann Anat. 2010;192(5):275–283. doi:10.1016/j.aanat.2010.07.01020810260
   PubMed Web of Science ®Google Scholar
• Beishline K, Azizkhan-Clifford J. Sp1 and the ‘hallmarks of cancer’. Febs J. 2015;282(2):224–258. doi:10.1111/febs.1314825393971
   PubMed Web of Science ®Google Scholar
• Safe S, Abdelrahim M. Sp transcription factor family and its role in cancer. Eur J Cancer. 2005;41(16):2438–2448. doi:10.1016/j.ejca.2005.08.00616209919
   PubMed Web of Science ®Google Scholar
• Hoppe-Seyler F, Butz K. Activation of human papillomavirus type 18 E6-E7 oncogene expression by transcription factor Sp1. Nucleic Acids Res. 1992;20(24):6701–6706. doi:10.1093/nar/20.24.67011336181
   PubMed Web of Science ®Google Scholar
• Wang F, Li Y, Zhou J, et al. miR-375 is down-regulated in squamous cervical cancer and inhibits cell migration and invasion via targeting transcription factor SP1. Am J Pathol. 2011;179(5):2580–2588. doi:10.1016/j.ajpath.2011.07.03721945323
   PubMed Web of Science ®Google Scholar
• Choi ES, Nam JS, Jung JY, Cho NP, Cho SD. Modulation of specificity protein 1 by mithramycin A as a novel therapeutic strategy for cervical cancer. Sci Rep. 2014;4:7162. doi:10.1038/srep0716225418289
   PubMed Web of Science ®Google Scholar
• Eriksson D, Lofroth PO, Johansson L, Riklund KA, Stigbrand T. Cell cycle disturbances and mitotic catastrophes in HeLa Hep2 cells following 2.5 to 10 Gy of ionizing radiation. Clin Cancer Res. 2007;13(18 Pt 2):5501s–5508s. doi:10.1158/1078-0432.CCR-07-098017875782
   PubMed Web of Science ®Google Scholar
• Montenegro MF, Sanchez-del-Campo L, Fernandez-Perez MP, Saez-Ayala M, Cabezas-Herrera J, Rodriguez-Lopez JN. Targeting the epigenetic machinery of cancer cells. Oncogene. 2015;34(2):135–143. doi:10.1038/onc.2013.60524469033
   PubMed Web of Science ®Google Scholar
• Sewing A, Wiseman B, Lloyd AC, Land H. High-intensity Raf signal causes cell cycle arrest mediated by p21Cip1. Mol Cell Biol. 1997;17(9):5588–5597. doi:10.1128/mcb.17.9.55889271434
   PubMed Web of Science ®Google Scholar
• Cho HJ, Oh YJ, Han SH, et al. Cdk1 protein-mediated phosphorylation of receptor-associated protein 80 (RAP80) serine 677 modulates DNA damage-induced G2/M checkpoint and cell survival. J Biol Chem. 2013;288(6):3768–3776. doi:10.1074/jbc.M112.40129923264621
   PubMed Web of Science ®Google Scholar
• Tao S, Meng S, Zheng X, Xie L. ATM participates in the regulation of viability and cell cycle via ellipticine in bladder cancer. Mol Med Rep. 2017;15(3):1143–1148. doi:10.3892/mmr.2017.614128138703
   PubMed Web of Science ®Google Scholar
• Iwahori S, Yasui Y, Kudoh A, et al. Identification of phosphorylation sites on transcription factor Sp1 in response to DNA damage and its accumulation at damaged sites. Cell Signal. 2008;20(10):1795–1803. doi:10.1016/j.cellsig.2008.06.00718619531
   PubMed Web of Science ®Google Scholar
• Nishida Y, Mizutani N, Inoue M, et al. Phosphorylated Sp1 is the regulator of DNA-PKcs and DNA ligase IV transcription of daunorubicin-resistant leukemia cell lines. Biochim Biophys Acta. 2014;1839(4):265–274. doi:10.1016/j.bbagrm.2014.02.00424530422
   PubMed Web of Science ®Google Scholar
• Chen XJ, Han LF, Wu XG, et al. Clinical significance of CD163+ and CD68+ tumor-associated macrophages in high-risk HPV-related cervical cancer. J Cancer. 2017;8(18):3868–3875. doi:10.7150/jca.2144429151975
   PubMed Web of Science ®Google Scholar
• Barash U, Lapidot M, Zohar Y, et al. Involvement of heparanase in the pathogenesis of mesothelioma: basic aspects and clinical applications. J Natl Cancer Inst. 2018;110(10):1102–1114. doi:10.1093/jnci/djy03229579286
   PubMedGoogle Scholar
• Dizon DS, Mackay HJ, Thomas GM, et al. State of the science in cervical cancer: where we are today and where we need to go. Cancer. 2014;120(15):2282–2288. doi:10.1002/cncr.2872224737608
   PubMed Web of Science ®Google Scholar
• Zhang L, Liu SK, Song L, Yao HR. SP1-induced up-regulation of lncRNA LUCAT1 promotes proliferation, migration and invasion of cervical cancer by sponging miR-181a. Artif Cells Nanomed Biotechnol. 2019;47(1):556–564. doi:10.1080/21691401.2019.157584030831032
   PubMed Web of Science ®Google Scholar
• Pore N, Gupta AK, Cerniglia GJ, et al. Nelfinavir down-regulates hypoxia-inducible factor 1alpha and VEGF expression and increases tumor oxygenation: implications for radiotherapy. Cancer Res. 2006;66(18):9252–9259. doi:10.1158/0008-5472.CAN-06-123916982770
   PubMed Web of Science ®Google Scholar
• Criswell T, Leskov K, Miyamoto S, Luo G, Boothman DA. Transcription factors activated in mammalian cells after clinically relevant doses of ionizing radiation. Oncogene. 2003;22(37):5813–5827. doi:10.1038/sj.onc.120668012947388
   PubMed Web of Science ®Google Scholar
• Yang CR, Wilson-Van PC, Planchon SM, et al. Coordinate modulation of Sp1, NF-kappa B, and p53 in confluent human malignant melanoma cells after ionizing radiation. Faseb J. 2000;14(2):379–390. doi:10.1096/fasebj.14.2.37910657994
   PubMed Web of Science ®Google Scholar
• Wang X, Li Q, Jin H, et al. miR-424 acts as a tumor radiosensitizer by targeting aprataxin in cervical cancer. Oncotarget. 2016;7(47):77508–77515. doi:10.18632/oncotarget.1271627769049
   PubMedGoogle Scholar
• Ke G, Liang L, Yang JM, et al. MiR-181a confers resistance of cervical cancer to radiation therapy through targeting the pro-apoptotic PRKCD gene. Oncogene. 2013;32(25):3019–3027. doi:10.1038/onc.2012.32322847611
   PubMed Web of Science ®Google Scholar
• Basu AK, Damage DNA. Mutagenesis and Cancer. Int J Mol Sci. 2018;19(4). doi:10.3390/ijms19040970
   Web of Science ®Google Scholar
• Pawlik TM, Keyomarsi K. Role of cell cycle in mediating sensitivity to radiotherapy. Int J Radiat Oncol Biol Phys. 2004;59(4):928–942. doi:10.1016/j.ijrobp.2004.03.00515234026
   PubMed Web of Science ®Google Scholar
• An Z, Muthusami S, Yu JR, Park WY. T0070907, a PPAR gamma inhibitor, induced G2/M arrest enhances the effect of radiation in human cervical cancer cells through mitotic catastrophe. Reprod Sci. 2014;21(11):1352–1361. doi:10.1177/193371911452526524642720
   PubMed Web of Science ®Google Scholar
• Nurse P. Universal control mechanism regulating onset of M-phase. Nature. 1990;344(6266):503–508. doi:10.1038/344503a02138713
   PubMed Web of Science ®Google Scholar
• Sung WW, Lin YM, Wu PR, et al. High nuclear/cytoplasmic ratio of Cdk1 expression predicts poor prognosis in colorectal cancer patients. Bmc Cancer. 2014;14:951. doi:10.1186/1471-2407-14-95125511643
   PubMed Web of Science ®Google Scholar
• Chen S, Chen X, Xiu YL, Sun KX, Zhao Y. MicroRNA-490-3P targets CDK1 and inhibits ovarian epithelial carcinoma tumorigenesis and progression. Cancer Lett. 2015;362(1):122–130. doi:10.1016/j.canlet.2015.03.02925819031
   PubMed Web of Science ®Google Scholar
• Kori M, Yalcin AK. Potential biomarkers and therapeutic targets in cervical cancer: insights from the meta-analysis of transcriptomics data within network biomedicine perspective. PLoS One. 2018;13(7):e200717. doi:10.1371/journal.pone.0200717
   PubMed Web of Science ®Google Scholar
• Jayanthi V, Das AB, Saxena U. Grade-specific diagnostic and prognostic biomarkers in breast cancer. Genomics. 2019. doi:10.1016/j.ygeno.2019.03.001
   PubMed Web of Science ®Google Scholar
• Alexandrou AT, Li JJ. Cell cycle regulators guide mitochondrial activity in radiation-induced adaptive response. Antioxid Redox Signal. 2014;20(9):1463–1480. doi:10.1089/ars.2013.568424180340
   PubMed Web of Science ®Google Scholar